Replies to post #3226 on Adamis Pharmaceuticals Corp (ADMP)

[Moeclay]

Late financials and pending litigation would be my guess. Not to mention that big pharm is already in late stage trials of an oral covid treatment.

My guess is that regulators will favor big pharm as usual.

https://www.marketwatch.com/story/merck-ridgeback-start-phase-3-trial-of-oral-drug-to-prevent-covid-19-2021-09-01

https://www.usnews.com/news/top-news/articles/2021-09-01/pfizer-starts-dosing-patients-in-oral-covid-19-drug-trial